Jefferies Financial Group Trims Aurinia Pharmaceuticals (NASDAQ:AUPH) Target Price to $9.00
Aurinia Pharmaceuticals (NASDAQ:AUPH – Free Report) (TSE:AUP) had its price objective decreased by Jefferies Financial Group from $9.50 to $9.00 in a research report report published on Friday, BayStreet.CA reports. Jefferies Financial Group currently has a hold rating on the biotechnology company’s stock. Separately, Royal Bank of Canada lowered their price objective on Aurinia Pharmaceuticals […]
More Stories
Segment Wealth Management LLC Grows Stake in Intercontinental Exchange, Inc. (NYSE:ICE)
Segment Wealth Management LLC increased its position in shares of Intercontinental Exchange, Inc. (NYSE:ICE – Free Report) by 0.9% in...
Greenleaf Trust Increases Position in iShares Intermediate Government/Credit Bond ETF (BATS:GVI)
Greenleaf Trust grew its position in shares of iShares Intermediate Government/Credit Bond ETF (BATS:GVI – Free Report) by 4.2% during...
McKesson Co. (NYSE:MCK) Shares Acquired by Greenleaf Trust
Greenleaf Trust boosted its holdings in McKesson Co. (NYSE:MCK – Free Report) by 62.0% during the 3rd quarter, according to...
Greenleaf Trust Buys 18,921 Shares of Comcast Co. (NASDAQ:CMCSA)
Greenleaf Trust boosted its stake in Comcast Co. (NASDAQ:CMCSA – Free Report) by 20.5% during the 3rd quarter, according to...
Plan Group Financial LLC Boosts Position in iShares Russell Mid-Cap ETF (NYSEARCA:IWR)
Plan Group Financial LLC grew its holdings in shares of iShares Russell Mid-Cap ETF (NYSEARCA:IWR – Free Report) by 6.4%...
Autodesk, Inc. (NASDAQ:ADSK) Shares Acquired by Greenleaf Trust
Greenleaf Trust lifted its position in shares of Autodesk, Inc. (NASDAQ:ADSK – Free Report) by 1.3% in the third quarter,...